Regulatory bodies

The medicines regulator has ordered an online pharmacy to amend its advertising for medication “not licensed for weight loss” following a complaint, it has revealed.

An ejaculation “delay spray” has been recalled as a “precautionary measure” after a company admitted selling the product “containing lidocaine without authorisation” from the MHRA.

The Northern Irish pharmacy regulator has revealed proposals for a fee rise, having made a pre-tax loss of almost £200,000.

The medicines watchdog has received reports of some 10 deaths “with glucagon-like peptide-1 receptor agonists (GLP-1RAs) indicated for weight management” such as Wegovy and Mounjaro, C+D can reveal.

A GP pharmacist and independent prescriber has been slapped with a warning after providing prescriptions to family and friends while being signed off as “medically unfit to work”.

A batch of anti-seizure medicine has been recalled as a “precautionary measure” after a patient discovered a small piece of metal inside a tablet, the pharmacy negotiator has announced.

The medicines watchdog has revealed that almost 50 patients have been hospitalised “in association with glucagon-like peptide-1 receptor agonists (GLP-1RAs)”.

The General Pharmaceutical Council (GPhC) has found that the fitness to practise (FtP) of a pharmacist who “crashed” her company Citroen Berlingo van after drinking “six large drinks of her husband’s home brew” is “no longer impaired”.

The pharmacy regulator is set to change up its “three-pronged” pharmacy inspection approach, it has announced.

The Care Quality Commission (CQC) is set to fill the “legal loophole” that currently leaves pharmacist-owned-businesses that are run from unregistered premises completely unregulated, the pharmacy regulator has said.